Dior-PG1 Tablet ER
Marketer
Sain Medicaments Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Dior-PG1 Tablet ER
PG1-Dior Extended-Release tablets combine medications to effectively manage blood glucose. This treatment, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin utilization, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for PG1-Dior ER tablets. Take with food to minimize gastric discomfort. If a dose is missed, take it immediately; however, if nearing the next dose, omit the missed one and resume your regular schedule. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may result in hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before treatment commences. Limit alcohol consumption as it may heighten the risk of side effects.
Uses of Dior-PG1 Tablet ER
Managing type 2 diabetes
Major Benefits of Dior-PG1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dior-PG1 Extended-Release tablets should be administered with food.
Common Side effects of Dior-PG1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Dior-PG1 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dior-PG1 Tablet ER. Ingest the tablet whole; do not chew, crush, or divide it. Consume this medication with food.
How Dior-PG1 Tablet ER works:
Dior-PG1 ER tablets contain a triple-drug formulation for diabetes management: glimepiride, metformin, and pioglitazone. These medications employ distinct actions to optimize blood glucose regulation when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, functions by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Dior-PG1 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Dior-PG1 tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dior-PG1 tablets likely pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, with the possibility of negative consequences for the child.
DrivingCAUTION
Driving may be impaired if your blood glucose levels are abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyCAUTION
Exercise caution when prescribing Dior-PG1 Tablet ER to patients with impaired renal function; dosage modification may be necessary. Consult a physician before administering. Dior-PG1 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Dior-PG1 Tablet ER cautiously, potentially requiring a modified dosage. Physician consultation is advised. Dior-PG1 Tablet ER is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Dior-PG1 Tablet ER :
Should you forget a dose of Dior-PG1 Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Dior-PG1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently